Fount of Information

TriLink BioTechnologies社 April 2024 TriLink Messenger




Research news

Advances in delivery of mRNA by lipid nanoparticles

New research explores the potential of lipid nanoparticles (LNPs) for mRNA delivery in vaccines and therapeutics, highlighting advancements in immunogenicity, tissue specificity, and targeted delivery. Studies demonstrate the development of LNPs with improved safety profiles for enhancing immune responses and reducing off-target effects. Exciting innovations in in vivo editing of hematopoietic stem cells offer promising avenues for treating genetic disorders, potentially revolutionizing current treatment approaches.


Our latest advancements

Discover our new tools and products


OligoBuilder® tool

Engineered to expedite the delivery of complex oligonucleotide constructs, including heavily modified sequences—TriLink's specialty—our new OligoBuilder® tool empowers you to get the oligos you need to focus on your research.

Build my oligos  ➔


New premade mRNAs

We are excited to announce the availability of six new mRNA constructs – capped with TriLink's best-to-date analog CleanCap® M6 and modified with proven N1-metheylpseudourine – to provide more robust performance.

View new products  ➔

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。